Abstract
Background: Choices of antibacterial for infections in pregnancy are limited because of potential risks to the fetus, particularly in the early months. However, infections may result in preterm labour or other problems and so treatment is needed. Increasingly, resistance is reported among common pathogens to older agents, such as ampicillin or amoxicillin, that have been widely used in pregnancy.
Objective: To assess the safety and efficacy of cefuroxime axetil in the treatment of infections during pregnancy.
Design: This was a retrospective analysis of case records for women who were treated with cefuroxime axetil at some point during pregnancy.
Setting: Patients were treated at one centre in Lubliniec, Poland in 1996 and 1997.
Patients and participants: The study included 78 women aged 19 to 38 years (mean 26 years) and their 80 infants.
Main outcome measures and results: Efficacy in treating maternal infections was assessed, and the physical and mental development of children born to treated mothers was evaluated for at least 18 months after birth. 13 women were treated in the first trimester, 19 in the second trimester and 46 in the third trimester. There were no abnormalities causing concern in terms of physical or mental development in any of the children, and no abnormality that was attributable to the treatment the mother had received.
Conclusions: The results add clinical support for the use of cefuroxime axetil in pregnancy if an antibacterial is needed, thus offering an alternative if antibacterial resistance to older agents is an issue for the pregnant mother.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Gamsu HR. Bacterial, fungal and protozoal infections in pregnancy and the newborn. In: Weatherall DJ, Ledingham JGG, Warrell DA, editors. Oxford textbook of medicine. CD version
Wise R. Prescribing in pregnancy: antibiotics. BMJ 1987; 294: 42–6
Physicians Desk Reference 53rd edition. Montvale (NJ): Medical Economics Company, 1999: 3019
Physicians Desk Reference 53rd edition. Montvale (NJ): Medical Economics Company, 1999: 920
Dyer IE, Sankary TM, Dawson JA. Antibiotic resistance in bacterial urinary tract infections, 1991 to 1997. West J Med 1998; 169(5): 265–8
Bousefield P, Browning AK, Mullinger BM, at al. Cefuroxime: potential use in pregnant women at term. Br J Obstet Gynaecol 1981; 88: 146–9
Craft I, Mullinger BM, Kennedy MRK. Placental transfer of cefuroxime. Br J Obstet Gynaecol 1981; 88: 141–5
Physicians Desk Reference 53rd edition. Montvale (NJ): Medical Economics Company, 1999: 1098
Perry CM, Brogden RN. Cefuroxime axetil: a review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy. Drugs 1996; 52(1): 125–58
Hamilton P. Care of the newborn in the delivery room. BMJ 1999; 318: 1403–6
Rubin PC. Prescribing in pregnancy. In: Weatherall DJ, Ledingham JGG, Warrell DA, editors. Oxford textbook of medicine. CD version
Craft I. Placental transfer of cephalosporins. Res Clin Forums 1984; 6(2): 45–52
Chow AW, Jewesson PJ. Pharmacokinetics and safety of antimicrobial agents during pregnancy. Rev Infect Dis 1985; 7(3): 287–313
Cefuroxime. In: Briggs GG, Freeman RK, Yaffe SJ, editors. Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. 5th edition. Baltimore (MD): Williams & Wilkins, 1988: 169/c
De Louvois J. Cefuroxime in treatment of neonates. Arch Dis Child 1982; 57: 59–62
Wilkinson PJ, Belohradsky BH, Marget W. A clinical study of cefuroxime in neonates. Proc R Soc Med 1977; 70Suppl. 9: 183–7
Salvioli GP, Camerlo F. Evolution of antibiotic treatment with beta-lactams: the methoximines. Proceedings of an International Conference; 1980 Apr 25-26; Rome. Milan: Masson Italia Editori, 1982: 131–4
Jafusco F, Ansanelli V, Di Lena C. The therapeutic use of cefuroxime in neonates. Proceedings of an International Conference; 1980 Apr 25-26; Rome. Milan: Masson Italia Editori, 1982: 151–9
Sutton A, Fleet H, Ng SH, et al. The role of cefuroxime and gentamicin in neonates: a comparative study. In: Cefuroxime update. R Soc Med Int Congr Symp 19; 38: 153–61
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Manka, W., Solowiow, R. & Okrzeja, D. Assessment of Infant Development During an 18-Month Follow-Up After Treatment of Infections in Pregnant Women with Cefuroxime Axetil. Drug-Safety 22, 83–88 (2000). https://doi.org/10.2165/00002018-200022010-00007
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002018-200022010-00007